Tumor necrosis factor as a therapeutic target of rheumatologic disease.
about
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophagesTargeting TNF receptors in rheumatoid arthritisEffects of some acupoints (Du-14, Li-11, St-36, and Sp-6) on serum TNF-α and hsCRP levels in healthy young subjectsCharacterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α.Distressed personality is associated with lower psychological well-being and life satisfaction, but not disability or disease activity in rheumatoid arthritis patientsNovel Human Three-Domain Antibody Fragments Against sTNFα as Well as tmTNFα with High Affinity Generated by the Combination of Ribosome Display and E. coli Expression System.Reduction of burn progression with topical delivery of (antitumor necrosis factor-α)-hyaluronic acid conjugates.Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitisCommon inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.Adverse effects of golimumab in the treatment of rheumatologic diseases.Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review.Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-alpha treatments.Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF TherapyTumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting system.TNF-α inhibitory effect of Euphorbia hirta in rats.Synergistic effects of cyclic strain and Th1-like cytokines on tenascin-C production by rheumatic aortic valve interstitial cells.Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up.
P2860
Q24288996-B61379D4-8C18-473F-9E57-ACB2D812CDCDQ26853279-FCA0A880-9629-49AF-97EA-47D3DABF9D90Q34805959-ADA50CD1-C588-41BE-9B5B-6688CEEA9CA6Q35232352-5C25A793-527E-4EDB-BD8E-A3E20A36EDDCQ35859109-9FD383C3-7133-4115-920D-7FA91B85FB1CQ35918691-C5B75A03-9F83-419A-AC3C-00C51138A533Q36074738-63D856CD-B74A-4BE7-9379-14D1D812C46AQ37294508-60996553-80D9-41EA-A03A-9F546F98F859Q37300823-54F403AF-F026-4F78-94B5-7CE0A9309969Q38132273-9797BAC7-3257-4214-B711-0F509C6F5A1CQ38201788-C12386BC-ADCF-459F-BF0B-780A080BEBB9Q38337833-CCC8879A-31D1-4C9D-9EF1-1A915EAE318FQ38616681-58A0D0EE-033D-4CA6-90AB-D3767A35752CQ45062333-CF33ABE7-08A5-4445-81E2-4F6C6F52CC01Q45135619-A229892C-2264-4CB2-839C-EAD823E37903Q47210142-6183F913-4E11-4CBE-9C43-03B6C5BE8671Q50903093-CF9122F9-FB34-4775-8D06-9FD643207C30
P2860
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
@en
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
@nl
type
label
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
@en
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
@nl
prefLabel
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
@en
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
@nl
P2860
P1476
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
@en
P2093
Arthur Kavanaugh
Christoph Ackermann
P2860
P304
P356
10.1517/14728222.11.11.1369
P407
P577
2007-11-01T00:00:00Z